Sugi Holdings Co Ltd

Common Name

Sugi Holdings

Country

Japan

Sector

Healthcare

Industry

Pharmaceutical Retailers

Employees

11,820

Ticker

7649

Exchange

TOKYO STOCK EXCHANGE

Website

www.sugi-hd.co.jp

Description

Sugi Holdings Co., Ltd. operates as a leading retail company in Japan, primarily focusing on the distribution and management of drugstores and pharmacies. The company plays a crucial role in the healt... Show more

Financial Statements of Sugi Holdings

Below are the financial statements of Sugi Holdings, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of JPY	2025	2024
Net sales	878.02^a	744.48^a
Cost of sales	-602.98^a	-515.64^a
Gross profit	275.04^a	228.84^a
Selling, general and administrative expenses	—	—
Salaries, allowances and bonuses	-92.52^a	-76.65^a
Provision for bonuses	-3.99^a	-2.88^a
Retirement benefit expenses	-2.33^a	-1.65^a
Rent expenses	-44^a	-37.77^a
Other	-89.63^a	-73.27^a
Total selling, general and administrative expenses	-232.48^a	-192.22^a
Operating income	42.56^a	36.62^a
Non-operating income	—	—
Interest income	0.92^a	0.6^a
Dividend income	0.04^a	0.02^a
Gain on donation of non-current assets	0.38^a	0.63^a
Rental income	2.35^a	2.03^a
Subsidy income	0.6^a	0.19^a
Other	0.95^a	0.3^a
Total non-operating income	5.24^a	3.78^a
Non-operating expenses	—	—
Interest expenses	-0.23^a	-0.02^a
Rental costs	-2.08^a	-1.76^a
Loss on retirement of non-current assets	-0.39^a	-0.31^a
Share of loss of entities accounted for using equity method	-2.69^a	-0.04^a
Other	-0.43^a	-0.24^a
Total non-operating expenses	-5.81^a	-2.36^a
Ordinary income	41.99^a	38.04^a
Extraordinary income	—	—
Gain on sale of shares of subsidiaries and associates	0.31^a	0^a
Gain on sale of businesses	1^a	0^a
Total extraordinary income	1.31^a	0^a
Extraordinary losses	—	—
Impairment loss	-4.98^a	-4.96^a
Loss on valuation of investment securities	-0.24^a	-0.97^a
Total extraordinary losses	-5.22^a	-5.94^a
Profit before income taxes	38.08^a	32.1^a
Income taxes - current	-14.11^a	-12.59^a
Income taxes - deferred	-1.72^a	-2.47^a
Total income taxes	-12.39^a	-10.12^a
Net income	25.69^a	21.98^a
Profit attributable to owners of parent	25.69^a	21.98^a

Verified Sources Behind Sugi Holdings’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sugi Holdings’s data sources below and access millions more through our Disclosure Search.

a. Sugi Holdings's Integrated Report 2025

Trace every data point back to Sugi Holdings’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Sugi Holdings Co Ltd

Financial Statements of Sugi Holdings

Verified Sources Behind Sugi Holdings’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Sundrug Co Ltd

Cosmos Pharmaceutical Corp

Chugai Pharmaceutical Co Ltd

Sysmex Corp

Daiichi Sankyo Co Ltd

Astellas Pharma Inc